Boston Scientific (BSX) Amortization of Deferred Charges (2020 - 2026)

Boston Scientific has disclosed Amortization of Deferred Charges across 7 years of filings, most recently posting $4.0 million for Q2 2026.

• In Q2 2026, Amortization of Deferred Charges fell 89.19% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $20.0 million (down 88.17% YoY), while the FY2025 annual figure was $132.0 million, up 158.82% from the prior year.
• Amortization of Deferred Charges came in at $4.0 million for Q2 2026 at Boston Scientific, up from $2.0 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $81.0 million in Q1 2025 to a low of $2.0 million in Q1 2026.
• Average Amortization of Deferred Charges over 5 years is $18.9 million, with a median of $7.5 million recorded in 2022.
• Year-over-year, Amortization of Deferred Charges jumped 112.5% in 2022 and sank 97.53% in 2026.
• Over 5 years, Amortization of Deferred Charges stood at $7.0 million in 2022, then tumbled by 57.14% to $3.0 million in 2023, then surged by 1600.0% to $51.0 million in 2024, then plunged by 90.2% to $5.0 million in 2025, then retreated by 20.0% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $4.0 million in Q2 2026, $2.0 million in Q1 2026, and $5.0 million in Q4 2025.